Dr. Ann Clare Kessler
Member
Advisory Board
GenScript
Switzerland
Biography
Dr. Ann Clare Kessler currently serves on the Board of Directors of MedGenesis Therapeutix, Inc. as well as on the Science Advisory Board of Gen-Probe Inc. For more than thirty years, Dr. Kessler held several senior positions at Hoffmann-La Roche Inc. in the US, including Vice President and Head of Exploratory Research and VP of Pharmacology and Chemotherapy, prior to moving to Switzerland where she was in charge of the International Project Management group of Hoffmann-La Roche in Basel for another 5 years until 1995. Her managerial responsibilities in Research and Development concerned the discovery and development of novel drugs for global registration and launch in a number of therapeutic areas, including nervous system disorders. She has authored over 100 publications dealing with obesity, lipid metabolism and appetite regulation, and has 20 patents issued concerning pharmacological approaches to diseases. Dr. Ann Kessler obtained her B.S. degree from the College of Notre Dame of Maryland in 1965, M.S. in Biological Sciences from Northwestern University, in 1967, and a Ph.D. in Biochemistry from New York University in 1973.
Research Interest
Biochemistry , Pharmacology and Chemotherapy, business management
